National Vision Q2 Earnings Beat, Raises Profit Outlook on Margin Expansion
EYE sits 53% above its 52-week low of $14.75.
Summary
National Vision reported Q2 adjusted operating income of $31.6 million, up 33% year-over-year, and raised its full-year profit guidance. The results reflect a strategic shift toward higher-margin customers and cost discipline.
Key Events · Earnings and Guidance · EYE
-
Q2 Adjusted Operating Income Surges 33%
Adjusted operating income reached $31.6 million, up from $23.8 million a year ago, with adjusted operating margin expanding 140 basis points to 6.3%.
-
Full-Year Profit Guidance Raised
Management lifted its adjusted operating income outlook to $119–$139 million, a $12 million increase at the midpoint, while tightening adjusted comparable store sales growth to 3.0–5.0%.
-
Strategic Shift Boosts Profitability
Higher-value transactions, managed care customers, and ticket growth offset lower self-pay traffic, driving net income margin to 2.5% from 1.8%.
-
$20M in Share Repurchases During Q2
The company bought back 1.2 million shares for $20 million, with $30 million remaining under its authorization. No borrowings outstanding on its $300 million revolver.
Analysis · EYE · Industrial Applications And Services
National Vision delivered a strong Q2 with adjusted operating income jumping 33% to $31.6 million, driven by higher-value transactions and cost discipline. Management raised its full-year adjusted operating income guidance by $12 million at the midpoint, signaling confidence in the earnings power of its strategic transformation. The company also tightened its comparable store sales growth outlook, reflecting a deliberate shift toward a healthier customer mix that is boosting profitability even as lower-value traffic declines. With $30 million remaining on its buyback and no debt drawn on its $300 million revolver, the balance sheet supports continued share repurchases.
At the time of this filing, EYE was trading at $22.56 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $14.75 to $30.02. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.